Connect with us

Media OutReach

Bora Pharmaceuticals to Sponsor “Berkeley Dialogue” in Taipei, Advancing the Biopharma R&D and Supply Chain

Published

on

Bora to discuss a recent collaboration with Therapi AI, highlighting its focus on strengthening operational execution across the biopharma development cycle and supply chain through AI-enabled technologies

HONG KONG SAR – Media OutReach Newswire – 9 February 2026 – Bora Pharmaceuticals (Taiwan Stock Exchange: 6472.TW; OTCQX: BORAY), a pharmaceutical services company operating under a differentiated “Dual-Engine” strategy that integrates a global contract development and manufacturing organization (CDMO) with an innovative specialty pharmaceuticals business, announces its sponsorship of UC Berkeley ahead of the “Berkeley Dialogue” in Taipei. The event extends the platform that UC Berkeley has built for connecting executives from promising Asian biotech and medtech companies with global venture capital and academic leaders.

The “Berkeley Dialogue: Biotechnology & Drug Development”, held in parallel with a healthcare conference taking place at Regent Taipei, is designed to address an increasingly central challenge to founders and investors alike: how innovation and capital originating in Asia can be translated into globally executable and commercially scalable programs. The Berkeley Dialogue 2026 is a flagship forum series hosted by the Berkeley Club of Taiwan and supported by Bora Group to bring together academic leadership and industry insights around early discovery, development and scale up. Convened by Bobby Sheng, chairman & CEO of Bora Pharmaceuticals and former president of the Berkeley Club of Taiwan, alongside 8 distinguished UC Berkeley deans, 2 Nobel Laureates Fred Ramsdell and Omar Yaghi, and Chancellor Richard K. Lyons, the Dialogue will address global collaboration, innovation ecosystems, and AI-empowered drug development in the global biomedical landscape.

As an integrated CDMO with operations spanning Asia and North America, Bora supports programs originating in Asia as they advance toward U.S. and global clinical development and commercial manufacturing. The Company positions itself as a de-risking bridge across regions, applying consistent execution discipline and quality standards as programs scale.

“Asia has no shortage of strong science,” said Bobby Sheng. “The differentiator today is whether programs are built early with global execution in mind. Our role is to help emerging companies reduce downstream risk by aligning development, quality, and manufacturing decisions from the outset.” By bringing founders, scientists, and investors into the same conversation early, the Company aims to help address execution risk before it becomes a constraint on valuation, timelines, or scalability.

At “Berkeley Dialogue”, Bora will provide an overview of a recent partnership with Therapi AI, reflecting its focus on strengthening operational execution through technology. Bobby will share Bora’s perspective on the practical application of AI in biotech manufacturing and development, emphasizing the importance of building internal, knowledge-driven systems that enhance decision-making rather than chasing experimental use cases.

“AI will matter most where it improves reliability and execution,” Bobby added. “For us, that means applying it deliberately within our operations to capture institutional knowledge, improve efficiency, and support more predictable outcomes for our partners.”

Bora’s participation reflects a clear view of the next phase of Asian biotech growth where success will be defined less by novelty and more by execution credibility. By engaging early at the intersection of science, capital, and manufacturing, Bora aims to support companies and investors seeking to build globally scalable assets with fewer surprises as programs mature.

Hashtag: #BoraPharmaceuticals

The issuer is solely responsible for the content of this announcement.

About Bora

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.

For more, please visit:

Media OutReach

MarsLab Introduces Singapore-Based AI Inference Infrastructure Roadmap for Enterprise and Edge Deployment

Published

on

MarsLab outlines a system-first approach to AI inference infrastructure for enterprise and edge deployment scenarios.

SINGAPORE – Media OutReach Newswire – 28 May 2026 – MarsLab Pte Ltd today introduced its Singapore-based AI inference infrastructure roadmap, focused on deployment-oriented systems for enterprise and edge AI workloads.
MarsLab takes a system-first approach to AI infrastructure, bringing together hardware systems, software stack integration, workload validation, and deployment economics. The company is focused on practical scenarios where AI inference needs to operate reliably across real-world environments, including enterprise applications, edge deployment, and industry-specific systems.
MarsLab’s near-term M100 platform is designed for commercial and system-level validation. The platform is intended to help the company evaluate real workloads, software behavior, integration requirements, operational constraints, and customer deployment needs. These learnings will support MarsLab’s longer-term M200 roadmap, which is planned as a future self-designed silicon direction informed by practical deployment data.
“We believe future AI infrastructure should be developed with a system-first mindset,” said Zhongwei Liao, CEO of MarsLab. “Before moving toward deeper technology roadmaps, it is important to understand real workloads, system integration requirements, and deployment economics in practical environments.”
MarsLab is building its presence in Singapore and engaging with partners across Southeast Asia’s semiconductor and AI infrastructure ecosystem. The company aims to support enterprises and technology partners seeking practical, efficient, and deployable AI inference infrastructure.

Hashtag: #AIInfrastructure #AIInference #EdgeAI #EnterpriseAI #Singapore


The issuer is solely responsible for the content of this announcement.

About MarsLab Pte Ltd

MarsLab Pte Ltd is a Singapore-based AI inference infrastructure company focused on enterprise and edge AI deployment scenarios. The company works across hardware systems, software stack integration, workload validation, and deployment economics, with a system-first approach to practical AI infrastructure.

Continue Reading

Media OutReach

CP AXTRA Partners with Ayala to Strengthen Mall Development and Asset Management

Published

on

BANGKOK, THAILAND – Media OutReach Newswire – 28 May 2026 – CP AXTRA Public Company Limited, the operator of ASEAN’s leading wholesaler – retailer Makro and Lotus’s, will strengthen mall development and asset management at Makro in Thailand under a Memorandum of Cooperation (MoC) signed with Ayala Corporation, one of the Philippines’ largest conglomerates. Through its consumer retail and mall arms, ACx Holdings Corporation (“ACx”) and AyalaLand Malls, Inc (“ALMI”), the partnership will also unlock greater shared value from CP AXTRA’s mall assets nationwide.

Under the agreement, ACx and ALMI will share methodologies and best practices in mall asset operations, leasing strategy and project development to improve operational efficiency, enhance customer experience and maximize the long-term value of CP AXTRA’s land and assets, initially focusing on seven key stores of Makro. The parties will also explore future investment opportunities related to mall and asset development in Thailand, alongside collaborative initiatives for the development of new sites and the redevelopment of existing CP AXTRA sites across the country. This is the third agreement signed between CP AXTRA and Ayala, underscoring the strong partnership and continued collaboration between the two groups, following their previous agreements to operate Makro in the Philippines and expand regional business opportunities.

“This agreement with Ayala allows us to combine CP AXTRA’s deep understanding of the Thai retail market with Ayala’s decades of experience in developing and leasing shopping mall spaces. By applying proven methodologies to our Makro mall, we aim to elevate the standards of the retail environment we offer, not only improving the experience for our shoppers and tenants, but also fostering sustainable growth and creating long-term value for our asset and the surrounding community,” said Tanit Chearavanont, Group Chief Wholesale Business Officer, CP AXTRA Public Company Limited.

“This is another milestone in our growing relationship and collaboration with the CP Group. Through this partnership, we intend to leverage the complementary strengths of two leading conglomerates to create world-class retail and real estate developments across markets. This also marks Ayala’s entry into the Thailand market, giving us a strong opportunity not only to share our expertise, but also to gain valuable insights from one of Southeast Asia’s most dynamic and developed retail markets. More broadly, this partnership aligns with Ayala’s strategy of bringing the best of the world to the Philippines while showcasing the best of the Philippines to the world,” said Mark Uy, Managing Director and Group Head of Strategy and Business Development, Ayala Corporation.

“Makro’s nationwide footprint gives it a meaningful role in the everyday lives of Thai consumers. Our opportunity is to help turn that everyday relevance into places people choose to stay, explore, and return to. By combining CP AXTRA’s market knowledge with Ayala Malls’ experience in curating retail partners, improving customer journeys, and building community-oriented retail destinations, we believe these sites can become stronger platforms for shoppers, merchant partners, and long-term asset growth,” said Mariana Zobel de Ayala, Managing Director and Group Head of Leasing and Hospitality of Ayala Land.

The collaboration brings two complementary strengths together. CP AXTRA is one of ASEAN’s leading wholesale and retail operators, with more than 2,700 Makro and Lotus’s stores. The company is a regional leader in multi-format, omnichannel retail platforms across Southeast Asia and is advancing toward retail-tech company. ALMI, is one of the Philippines’ leading mall operators, managing 34 shopping centers recognized for their strong retail planning, curated tenant mix, and enhanced customer experience across Southeast Asia. With extensive expertise in leasing, mall operations, facility management, and mixed-use development, ALMI is well positioned to support CP AXTRA in maximizing the value and potential of its Makro mall assets in Thailand. Ayala Corporation also brings a broader consumer and enterprise ecosystem that can complement CP AXTRA’s regional retail expansion, while ACx, its consumer retail unit, adds perspective on evolving customer behavior, format innovation, and retail partnerships.

The MoC builds on the two groups’ existing strategic partnership, which began in 2025 with the formation of CP AXTRA AC CORPORATION to operate Makro stores in the Philippines and was expanded to include a wider range of collaborative opportunities. This new agreement deepens that partnership further, marking the first time Ayala will bring its mall development and leasing expertise directly to CP AXTRA’s operations in Thailand.

Hashtag: #CPAXTRA

The issuer is solely responsible for the content of this announcement.

About CP AXTRA

CP AXTRA Public Company Limited, is an operator of Asia’s leading wholesaler and retailer, Makro and Lotus’s. The Company is based in Thailand, with operation across 10 countries. CP AXTRA is committed to fulfilling people’s lives with good health, love, joy, and well-being, by providing solutions and meeting customers’ daily needs with technology, innovation, and operational excellence. With over 30 years of retail experience, CP AXTRA is a trusted partner for both B2B and B2C customers, offering a comprehensive range of products and services. Today, it manages over 2,700 offline stores in Thailand and Asia, with strong online presence.

About Ayala Corporation

For more than 190 years, Ayala Corporation has been building businesses that enable people to thrive.
Ayala, currently one of the largest conglomerates in the Philippines, has meaningful presence in real estate, banking, digital services and telecommunications, and renewable energy. It likewise has a growing presence in healthcare, mobility, and logistics as well as investments in industrial technologies, education, and other ventures. Ayala manages its corporate social responsibility initiatives through Ayala Foundation.

About Ayala Malls

Ayala Malls is the premier lifestyle mall network in the Philippines, known for creating vibrant, well-curated destinations that bring together shopping, dining, culture, and community experiences. With 34 malls nationwide, Ayala Malls continues to lead in elevating the Filipino retail experience by offering a diverse mix of global and local brands, innovative spaces, and enriching events that celebrate local creativity and inclusivity. As part of Ayala Land, the country’s leading real estate developer, Ayala Malls is committed to building dynamic, sustainable spaces where people can connect, thrive, and enjoy life’s everyday moments.

Continue Reading

Media OutReach

Aon Brings Leadership Forum to Manila to Help Organisations Navigate Risks and Drive Growth

Published

on

MANILA, PHILIPPINES – Media OutReach Newswire – 28 May 2026 – Aon plc (NYSE: AON), a leading global professional services firm, is today hosting its Better Decisions Leadership Forum in Manila, bringing together senior business leaders to discuss how organisations can navigate from risk to resilience and growth in an increasingly complex environment. The invitation-only forum is taking place at the Fairmont Hotel in Makati.

The event is expected to convene more than 70 C-suite and senior business leaders from top organisations across the Philippines for a closed-door exchange on managing economic, workforce, climate and operational pressures. By bringing together diverse perspectives, the forum aims to foster practical insights and strategies that help organisations navigate uncertainty, protect their businesses and drive sustainable growth.

The program will be officially opened by Karl Hamann, CEO of Philippines for Aon, followed by a keynote from Andrew Jeffries, country director for the Asian Development Bank on the macroeconomic and geopolitical trends shaping the business environment.

Notable speakers include Terence Williams, head of Commercial Risk in Asia Pacific for Aon, and other firm executives alongside external regional leaders, including Annacel Natividad, chief risk officer and sustainability head for Aboitiz Foods Group, and Raymond Martin Aguilar, vice president and head of risk and property management for Globe Telecom, Inc.

“This forum reflects a fundamental shift in how organisations are evolving their approach to risk,” said Williams. “Across Asia Pacific, we are seeing a growing focus on using data and analytics to understand trade-offs, test scenarios and act with greater confidence. Bringing leaders together to share practical experience is critical to strengthening resilience while continuing to drive growth.”

A central feature of the forum will be a C-suite panel on adaptive leadership in a digital world, where senior leaders will share how they are balancing risk, resilience and growth, and the decisions shaping their organisations today. The session will be moderated by Irma Gaviola, head of Commercial Risk, Philippines for Aon.

The program will include risk masterclasses focused on key enterprise exposures, including cyber and climate risks, exploring how organisations can quantify risk, strengthen resilience and design more effective risk transfer strategies.

Participants will also be introduced to Aon’s Risk Analyzers, an interactive environment where clients can experience a suite of analytics-led tools that support scenario testing and supports better risk capital decisions. The tools are designed to help organisations assess exposures and evaluate strategic choices in real time.

“The Philippines sits at the intersection of strong economic growth and increasing risk complexity, said Hamann. “This forum creates a space for candid dialogue and practical insights to help organisations navigate risk with greater clarity and confidence.”

The Better Decisions Leadership Forum is part of Aon’s ongoing commitment to helping organisations turn insight into action – enabling more informed decision-making to protect and grow their business.

Hashtag: #Aon

The issuer is solely responsible for the content of this announcement.

About Aon

(NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that help protect and grow their businesses.

Follow Aon on and sign up for news alerts .

Disclaimer
The information contained in this document is solely for information purposes, for general guidance only and is not intended to address the circumstances of any particular individual or entity. Although Aon endeavours to provide accurate and timely information and uses sources that it considers reliable, the firm does not warrant, represent or guarantee the accuracy, adequacy, completeness or fitness for any purpose of any content of this document and can accept no liability for any loss incurred in any way by any person who may rely on it. There can be no guarantee that the information contained in this document will remain accurate as on the date it is received or that it will continue to be accurate in the future. No individual or entity should make decisions or act based solely on the information contained herein without appropriate professional advice and targeted research.

Continue Reading

Trending